FDA approves first radioligand equivalent, Curium’s copycat of Novartis’ Lutathera
FDA approves first radioligand equivalent share.google/5hxFpe5L5dwy... FDA approves first radioligand equivalent, Curium’s copycat of Novartis’ Lutathera The FDA has approved the industry’s very first generic radioligand therapy, known as a radioligand equivalent. | The FDA has approved the industry’s first radioligand equivalent in Curium’s lutetium ...